NCT01832727 Phase 1b/2, Multicenter, Open-label Study of Oprozomib and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma Status TERMINATED Phase PHASE1/PHASE2
NCT01816971 Carfilzomib, Lenalidomide, and Dexamethasone Before and After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma Status COMPLETED Phase PHASE2
NCT01813227 A Phase II Study of Carfilzomib in Relapsed Waldenström's Macroglobulinemia (WM) IST-CAR-531 Status COMPLETED Phase PHASE2
NCT01812720 Carfilzomib and Dexamethasone in Treating Patients With Multiple Myeloma Who Previously Underwent a Stem Cell Transplant Status WITHDRAWN Phase PHASE2
NCT01807286 Pomalidomide With Melphalan and Dexamethasone for Untreated Systemic AL Amyloidosis Status TERMINATED Phase PHASE1
NCT01794520 Study Evaluating ABT-199 in Participants With Relapsed or Refractory Multiple Myeloma Status COMPLETED Phase PHASE1/PHASE2
NCT01794507 A Study Evaluating ABT-199 in Multiple Myeloma Subjects Who Are Receiving Bortezomib and Dexamethasone as Standard Therapy Status COMPLETED Phase PHASE1
NCT01794039 Pomalidomide or Lenalidomide and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma Previously Treated With Lenalidomide Status COMPLETED Phase PHASE2
NCT01789242 A Safety Study of Carfilzomib in Patients With Previously-Treated Systemic Light Chain Amyloidosis Status COMPLETED Phase PHASE1
NCT01788475 Safety and Effectiveness of Ozurdex Steroid Implants for DME After Vitrectomy Surgery Status TERMINATED Phase NA
NCT01782963 Lenalidomide/Bortezomib/Dexamethasone for Multiple Myeloma (MM) Status COMPLETED Phase PHASE2
NCT01772381 Dexamethasone in Prevention of Respiratory Morbidity in Elective Caesarean Section in Term Fetus Status COMPLETED Phase NA
NCT01769209 Bortezomib and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia Status COMPLETED Phase PHASE2
NCT01754402 Bendamustine + Pomalidomide + Dex in R/R Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT01749969 SAR650984 (Isatuximab), Lenalidomide, and Dexamethasone in Combination in RRMM Patients Status COMPLETED Phase PHASE1